Patents Examined by Ping Cao
-
Patent number: 10111902Abstract: Embodiments presented herein relate to various polymers. Some of the polymer embodiments are heparin binding polymers. Some embodiments of the heparin binding polymers can be employed to bind to heparin for methods such as separating, purifying, removing, and/or isolating heparin and heparin like molecules.Type: GrantFiled: February 23, 2015Date of Patent: October 30, 2018Assignee: University of British ColumbiaInventors: Jayachandran N. Kizhakkedathu, Rajesh A. Shenoi, Cedric J. Carter, Donald E. Brooks
-
Patent number: 10098971Abstract: The present disclosure relates to polymers which contain a hydrophobic and hydrophilic segment which is sensitive to pH. In some aspects, the polymers form a micelle which is sensitive to pH and results in a change in fluorescence based upon the particular pH. In some aspects, the disclosure also provides methods of using the polymers for the imaging of cellular or extracellular environment or delivering a drug.Type: GrantFiled: December 5, 2016Date of Patent: October 16, 2018Assignee: The Board of Regents of the University of Texas SystemInventors: Jinming Gao, Gang Huang, Tian Zhao, Xinpeng Ma, Yiguang Wang, Yang Li, Baran D. Sumer
-
Patent number: 10058489Abstract: The present disclosure relates to zinc oxide particles having a mean particle size (volume) distribution of about 400 nm to about 650 nm, where the zinc oxide particles are formed by gas phase plasma deposition without milling and remain discrete particles after formation. The present disclosure further relates to the use of the zinc oxide particles in a dispersion. The present disclosure further relates to the use of the zinc oxide particles in a sunscreen composition. The present disclosure further relates to a method of formulating the sunscreen composition.Type: GrantFiled: February 14, 2017Date of Patent: August 28, 2018Assignee: BASF SEInventors: Tatiana Drovetskaya, Marc N. G. De Mul
-
Patent number: 10052288Abstract: The invention relates to a formulation for the delayed and controlled delivery of an adsorbent into the lower intestine of mammals. The formulation includes a carrageenan and an adsorbent, such as activated charcoal. The invention further relates to uses of this formulation, in particular to pharmaceutical uses. In one embodiment, the formulation is used to eliminate or reduce the side effects in the intestine, in particular in the colon, of pharmaceutical agents that are administered as a treatment for a disorder, but that have side effects when they reach the late ileum, the caecum or the colon.Type: GrantFiled: July 5, 2017Date of Patent: August 21, 2018Assignee: DA VOLTERRAInventors: Francois Lescure, Jean De Gunzburg
-
Patent number: 10023483Abstract: The invention provides a liquid composition when used for maintenance of a body of water, the liquid composition comprising a solution of magnesium and potassium salts, at least one of which is a halide salt. Preferably, the liquid composition comprises Mg2+ from the magnesium salt in an amount of from about 6000 ppm to about 15 000 ppm; K+ from the potassium salt in an amount from about 40 000 ppm to about 120 000 ppm and hypohalite from the halide in an amount from about 100 000 ppm to about 400 000 ppm.Type: GrantFiled: July 10, 2012Date of Patent: July 17, 2018Assignee: ZODIAC GROUP AUSTRALIA PTY LTD.Inventor: Ross Leslie Palmer
-
Patent number: 10016350Abstract: The present invention describes cosmetic nanotechnology, comprising polymeric nanoparticles containing oil and UV filter, photoprotective compositions comprising polymeric nanoparticles described herein, methods of prevention of diseases of the skin, and processes for the preparation of the polymeric nanoparticles described herein.Type: GrantFiled: May 12, 2016Date of Patent: July 10, 2018Assignees: BIOLAB SANUS FARMACÊUTICA LTDA, UNIVERSIDADE FEDERAL DO RlO GRANDE DO SUL-UFRGSInventors: Adriana Raffin Pohlmann, Silvia Stanisçuaski Guterres, Alessandro Jäger
-
Patent number: 10010615Abstract: The presently described technology provides a novel class of prodrugs of quetiapine that can be synthesized by chemically conjugating amino acids. The present technology also provides methods of treating patients, pharmaceutical compositions and methods of synthesizing conjugates of the present technology.Type: GrantFiled: May 15, 2017Date of Patent: July 3, 2018Assignee: KemPharm, Inc.Inventors: Travis Mickle, Sven Guenther, Sanjib Bera
-
Patent number: 10004774Abstract: The present invention relates to a pharmaceutical formulation containing a combination of (a) at least one astringent active substance and (b) at least one mucilaginous drug and the use thereof for the prevention or treatment of inflammatory diseases of the oropharyngeal region and for the treatment of painful irritations of the mucosa in the oropharyngeal region and associated irritable cough.Type: GrantFiled: March 10, 2016Date of Patent: June 26, 2018Assignee: SANOFI-AVENTIS DEUTSCHLAND GMBHInventors: Julia Boni, Bernd Plohmann, Sandra Sauerland
-
Patent number: 9999578Abstract: Disclosed is a stable cosmetic composition having a syrupy texture while not being sticky, and translucent (or even transparent) appearance. Further disclosed is a method of preparation of such composition, as well as a method of its use.Type: GrantFiled: June 15, 2012Date of Patent: June 19, 2018Assignee: CHANEL PARFUMS BEAUTEInventors: Sophie Foucault, Veronique Kowandy, Veronique Trouillet
-
Patent number: 9999706Abstract: Implantable devices having antibacterial activity for preventing periprosthetic infections and for improving osteointegration capacity are provided. Methods for making and using such devices are also provided.Type: GrantFiled: March 24, 2011Date of Patent: June 19, 2018Assignee: NOBIL BIO RICERCHE S.R.L.Inventors: Daniele Bollati, Marco Morra, Clara Cassinelli, Giovanna Cascardo
-
Patent number: 9982139Abstract: A color metallic pigment according to the present invention contains at least a metallic pigment, an amorphous silicon oxide film layer that is formed on the surface of the metallic pigment, a metal oxide layer that is formed on the surface of the amorphous silicon oxide film layer and contains a metal oxide other than silicon oxide, and metal particles that are formed on the surface of the metal oxide layer, wherein the metal particles are so formed as to directly cover a part of the metal oxide layer.Type: GrantFiled: June 8, 2011Date of Patent: May 29, 2018Assignee: TOYO ALUMINIUM KABUSHIKI KAISHAInventors: Yoshiki Hashizume, Taro Morimitsu, Takayuki Nakao
-
Patent number: 9968533Abstract: The present invention describes cosmetic nanotechnology, comprising polymeric nanoparticles containing oil and UV filter, photoprotective compositions comprising polymeric nanoparticles described herein, methods of prevention of diseases of the skin, and processes for the preparation of the polymeric nanoparticles described herein.Type: GrantFiled: October 9, 2009Date of Patent: May 15, 2018Assignees: BIOLAB SANUS FARMACÊUTICAL LTDA, UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL—UFRGSInventors: Adriana Raffin Pohlmann, Silvia Stanisçuaski Guterres, Alessandro Jäger
-
Patent number: 9968562Abstract: The invention relates to a formulation for the delayed and controlled delivery of an adsorbent into the lower intestine of mammals. The formulation includes a carrageenan and an adsorbent, such as activated charcoal. The invention further relates to uses of this formulation, in particular to pharmaceutical uses. In one embodiment, the formulation is used to eliminate or reduce the side effects in the intestine, in particular in the colon, of pharmaceutical agents that are administered as a treatment for a disorder, but that have side effects when they reach the late ileum, the caecum or the colon.Type: GrantFiled: February 23, 2011Date of Patent: May 15, 2018Assignee: DA VOLTERRAInventors: Francois Lescure, Jean De Gunzburg
-
Patent number: 9963611Abstract: A composition for coating a polypropylene-based fabric or polypropylene-based material for use in decreasing the transmission of human pathogens. A device such as a protective face mask made from a polypropylene-based fabric or polypropylene-based material coated with the composition.Type: GrantFiled: May 21, 2010Date of Patent: May 8, 2018Assignee: Innonix Technologies, IncorporatedInventors: Neal G. Stewart, Francis Chi Nan Lau, Tai Wai Kung, Lok Yuen Lo, Dacey J. Ryan, Reid W. Von Borstel
-
Patent number: 9949930Abstract: Disclosed are oral dosage forms, comprising (i) a therapeutically effective amount of an opioid agonist; (ii) an opioid antagonist in releasable form; and (iii) a sequestered opioid antagonist which is not released when the dosage form is administered intact, and methods thereof.Type: GrantFiled: July 17, 2014Date of Patent: April 24, 2018Assignee: Purdue Pharma L.P.Inventors: Christopher Breder, Curtis Wright, Benjamin Oshlack
-
Patent number: 9937278Abstract: The present invention is directed to a biocompatible and preferably biodegradable gradient layer system comprising at least one set of layers comprising a biocompatible and preferably biodegradable cross-linked polymer and at least one biocompatible and preferably biodegradable support layer, wherein a gradient is preferably formed with respect to the mechanical and/or physical properties of one or more layers of the at least one set of layers comprising a biocompatible and biodegradable cross-linked polymer and/or the at least one biocompatible and preferably biodegradable support layer. The at least one support layer preferably comprises a biocompatible and preferably biodegradable meltable polymer and/or a biocompatible and incorporable material. This biocompatible and preferably biodegradable gradient layer system may be used as a biomaterial for regenerative medicine, particularly as a wound dressing or for tissue support.Type: GrantFiled: April 4, 2012Date of Patent: April 10, 2018Assignee: AMOR (SUZHOU) MEDICAL SCI-TECH CO., LTD.Inventors: Thorsten Steinberg, Pascal Tomakidi, Simon Schulz, Marco Angarano, Rolf Muelhaupt, Martin Fabritius
-
Patent number: 9889230Abstract: The present disclosure relates to collagen-containing implants including a porous substrate having a first hydrogel precursor and a second hydrogel precursor applied thereto in a manner such that the first hydrogel precursor and second hydrogel precursor do not react with each other until the implant is placed at the site of implantation and exposed to the physiological fluids of a patient.Type: GrantFiled: November 3, 2010Date of Patent: February 13, 2018Assignee: Covidien LPInventors: Steven Bennett, Timothy Sargeant
-
Patent number: 9855207Abstract: The present invention relates to an UV-photo-protecting cosmetic composition, including: (a) at least one aqueous phase, (b) at least one fatty phase, (c) at least one micronized organic UV-screening agent, the mean particle size of said micronized particles ranging from 0.01 to 2 ?m, and (d) at least one organomodified silicone which does not include poly(oxyalkylene) moieties.Type: GrantFiled: January 26, 2012Date of Patent: January 2, 2018Assignee: Momentive Performance Materials GmbHInventors: Sebastian Maaβ, Roland Wagner, Karl-Heinz Sockel, Mark Davis, Albert Schnering, Katharina Streicher
-
Patent number: 9757415Abstract: The present invention provides a pharmaceutical and/or veterinary composition comprising a retard release formulation of a Solarium glaucophyllum preparation. The composition further preferably comprises a calcium source. The composition of the invention is suitable to prevent and/or treat hypocalcaemia. Furthermore, the composition is suitable to prevent milk fever in cows. Advantageously, the composition is administered only once before calving so as to prevent the occurrence of mil fever in cows.Type: GrantFiled: February 4, 2014Date of Patent: September 12, 2017Assignee: HERBONIS AGInventors: Heinrich Bachmann, Walter Rambeck
-
Patent number: 9750667Abstract: A cleansing bar comprising at least one member chosen from clay and talc, wherein a total amount of clay and talc is present in an amount that is greater than any other material in the cleansing bar, at least one cleanser chosen from soap and surfactant, and a binder present in an amount to structure the cleansing bar into a bar.Type: GrantFiled: April 2, 2014Date of Patent: September 5, 2017Assignee: COLGATE-PALMOLIVE COMPANYInventors: Steve Misner, Long Pan, Diana Scala, Regina Hourigan, Ravi Subramanyam, Dennis Fletcher, Patricia Hall-Puzio, Shamim Ansari, Derek Le